stich
trial
associ
substudi
provid
great
deal
evid
effect
cabg
treatment
ischem
cardiomyopathi
nonetheless
also
left
sever
gap
knowledg
exampl
relationship
complic
surviv
analyz
th
postop
day
ascertain
patient
depress
lvef
wors
late
surviv
despit
optim
surgicalmed
manag
patient
normal
lv
function
discuss
risen
reason
unreason
employ
human
social
resourc
treatment
sever
patient
discuss
clinic
ethic
appear
everi
time
limit
contemporari
medic
knowledg
convict
healthcar
system
capac
overwhelm
ongo
pandem
pain
illustr
realiti
aspect
medic
commun
public
opinion
similar
sailor
ancient
world
face
humil
grief
pillar
hercul
mark
limit
possibl
ask
whether
capabl
push
beyond
sens
one
interpret
import
commend
work
omer
associ
consist
idea
cabg
recipi
preoper
lvef
surviv
multipl
sever
postop
complic
inde
present
wors
outcom
followup
outcom
like
due
overal
fragil
decondit
follow
complic
prolong
hospitalicu
stay
rather
heart
failur
lvef
associ
dosedepend
manner
risk
late
death
disturb
healthcar
provid
devot
major
effort
rescu
case
sever
postop
cours
intuit
consid
success
author
appropri
conclud
addit
energi
need
consecr
prevent
sever
postop
complic
subset
patient
yet
current
data
unfortun
provid
clue
pursu
target
one
must
underlin
import
extrem
vigil
patient
earli
postop
prompt
escal
level
care
respons
first
major
complic
order
prevent
addit
complic
occur
domino
effect
beyond
granular
strategi
hardli
emerg
herein
fact
vasqip
databas
tremend
sourc
valuabl
inform
current
paper
lack
potenti
signific
data
exampl
surgic
techniqu
beatingheart
onpump
cabg
propos
depress
lvef
activ
ischemia
number
outcom
patient
later
receiv
heart
transplant
lvad
implant
interact
complic
burden
demonstr
extent
myocardi
viabil
respect
surpris
late
myocardi
recoveri
scarc
investig
prospect
studi
despit
constitut
one
theoret
legitim
current
indic
cabg
limit
minor
impact
preval
male
patient
one
stich
substudi
demonstr
absenc
genderrel
differ
late
outcom
among
patient
mayb
greatest
valu
current
studi
lie
question
answer
open
well
troubl
time
experienc
